According to CoherentMI, The chemotherapy induced neutropenia (CIN) market is estimated to be valued at USD 14.88 Bn in 2025 and is expected to reach USD 21.08 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032. https://www.myvipon.com/post/1603356/Chemotherapy-Induced-Neutropenia-Treatment-Market-Estimated-amazon-coupons